In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 0.47 million shares changing hands with its beta currently measuring 0.09. Company’s recent per share price level of $2.79 trading at $0.25 or 9.84% at ring of the bell on the day assigns it a market valuation of $10.04M. That closing price of NLSP’s stock is at a discount of -473.48% from its 52-week high price of $16.00 and is indicating a premium of 53.41% from its 52-week low price of $1.30. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.25 million shares which gives us an average trading volume of 246.63K if we extend that period to 3-months.
For NLS Pharmaceutics Ltd (NLSP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Upright in the green during last session for gaining 9.84%, in the last five days NLSP remained trading in the green while hitting it’s week-highest on Friday, 06/27/25 when the stock touched $2.79 price level, adding 2.45% to its value on the day. NLS Pharmaceutics Ltd’s shares saw a change of -58.57% in year-to-date performance and have moved 15.77% in past 5-day. NLS Pharmaceutics Ltd (NASDAQ:NLSP) showed a performance of 20.26% in past 30-days. Number of shares sold short was 72299.0 shares which calculate 0.15 days to cover the short interests.
NLS Pharmaceutics Ltd (NLSP) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 33.06% during past 5 years.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
Insiders are in possession of 32.46% of company’s total shares while institution are holding 10.04 percent of that, with stock having share float percentage of 14.86%. Investors also watch the number of corporate investors in a company very closely, which is 10.04% institutions for NLS Pharmaceutics Ltd that are currently holding shares of the company. BVF INC/IL is the top institutional holder at NLSP for having 5.75 million shares of worth $1.25 million. And as of 2024-06-30, it was holding 15.0543 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 2.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0535 of outstanding shares, having a total worth of $0.5 million.
